A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine

A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine

Abstract Background Asthma is an independent risk factor for invasive pneumococcal disease; however, the immune response of adult asthma patients to pneumococcal vaccination is unknown. We explore the serologic response of patients with moderate to severe asthma to the 23-valent pneumococcal polysac...

Full description

Bibliographic Details
Main Authors: C. R. Laratta, K. Williams, D. Vethanayagam, M. Ulanova, H. Vliagoftis
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Invasive pneumococcal disease
Vaccination
Pneumococcal polysaccharide vaccine
Serology
Antibodies
Asthma
Online Access:http://link.springer.com/article/10.1186/s13223-017-0200-2

Internet

http://link.springer.com/article/10.1186/s13223-017-0200-2

Similar Items